KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 134 filers reported holding KARUNA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $6,391,871 | +649.5% | 29,476 | +527.8% | 0.31% | +830.3% |
Q1 2023 | $852,800 | -71.9% | 4,695 | -69.6% | 0.03% | -70.5% |
Q4 2022 | $3,037,301 | +185.7% | 15,457 | +84.4% | 0.11% | +180.0% |
Q1 2022 | $1,063,000 | -25.9% | 8,381 | -23.4% | 0.04% | -28.6% |
Q4 2021 | $1,434,000 | +378.0% | 10,946 | +181.8% | 0.06% | +40.0% |
Q3 2020 | $300,000 | – | 3,885 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 47,376 | $8,605,377 | 3.04% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |